Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BIOLASE Inc - SIC # 3843 - DENTAL EQUIPMENT AND SUPPLIES
Ticker
Exchange
SIC #
Website
Latest Ticker
BIOL
Nasdaq
3843
https://www.biolase.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BIOLASE Inc
BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024
- Mar 14th, 2024 10:30 am
Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
- Feb 22nd, 2024 11:30 am
Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
- Feb 20th, 2024 11:30 am
BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
- Feb 15th, 2024 7:45 pm
BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
- Feb 14th, 2024 11:30 am
BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
- Feb 13th, 2024 2:15 pm
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024
- Jan 29th, 2024 11:30 am
BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023
- Jan 8th, 2024 9:05 pm
BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
- Jan 3rd, 2024 9:05 pm
BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
- Dec 14th, 2023 9:05 pm
BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial
- Dec 12th, 2023 9:05 pm
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Dec 6th, 2023 6:46 pm
BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES
- Nov 9th, 2023 9:05 pm
Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIRĀ® Perio Protocol
- Nov 8th, 2023 11:30 am
BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023
- Nov 7th, 2023 9:05 pm
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
- Oct 18th, 2023 12:00 pm
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
- Sep 18th, 2023 8:30 pm
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
- Sep 14th, 2023 3:16 am
Q2 2023 BIOLASE Inc Earnings Call
- Aug 11th, 2023 9:26 am
BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
- Aug 10th, 2023 8:05 pm
Scroll